ClearBridge Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-394
| Closed | -$19K | – | 782 |
|
|
2020
Q2 | $19K | Hold |
394
| – | – | ﹤0.01% | 847 |
|
|
2020
Q1 | $17K | Sell |
394
-806
| -67% | -$34.8K | ﹤0.01% | 897 |
|
|
2019
Q4 | $49K | Buy |
1,200
+200
| +20% | +$8.17K | ﹤0.01% | 828 |
|
|
2019
Q3 | $36K | Hold |
1,000
| – | – | ﹤0.01% | 862 |
|
|
2019
Q2 | $27K | Hold |
1,000
| – | – | ﹤0.01% | 910 |
|
|
2019
Q1 | $27K | Buy |
+1,000
| New | +$27K | ﹤0.01% | 915 |
|
|
2018
Q2 | – | Sell |
-1,250
| Closed | -$28K | – | 1153 |
|
|
2018
Q1 | $28K | Hold |
1,250
| – | – | ﹤0.01% | 936 |
|
|
2017
Q4 | $38K | Buy |
1,250
+500
| +67% | +$15.2K | ﹤0.01% | 892 |
|
|
2017
Q3 | $28K | Hold |
750
| – | – | ﹤0.01% | 992 |
|
|
2017
Q2 | $21K | Sell |
750
-1,250
| -63% | -$35K | ﹤0.01% | 1034 |
|
|
2017
Q1 | $69K | Hold |
2,000
| – | – | ﹤0.01% | 841 |
|
|
2016
Q4 | $58K | Buy |
+2,000
| New | +$58K | ﹤0.01% | 873 |
|
|
2016
Q3 | – | Sell |
-500
| Closed | -$16K | – | 1116 |
|
|
2016
Q2 | $16K | Sell |
500
-500
| -50% | -$16K | ﹤0.01% | 952 |
|
|
2016
Q1 | $28K | Buy |
1,000
+400
| +67% | +$11.2K | ﹤0.01% | 917 |
|
|
2015
Q4 | $21K | Buy |
600
+100
| +20% | +$3.5K | ﹤0.01% | 974 |
|
|
2015
Q3 | $17K | Buy |
500
+200
| +67% | +$6.8K | ﹤0.01% | 1034 |
|
|
2015
Q2 | $13K | Buy |
+300
| New | +$13K | ﹤0.01% | 1056 |
|